Montefiore Medical Center
Hospital.
Based in NY
🤖
AI Overview
With $2.6M in lobbying spend across 29 quarterly filings, Montefiore Medical Center is a significant lobbying presence.
$2.6M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
2
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $180K |
| 2020 | $240K |
| 2021 | $270K |
| 2022 | $440K |
| 2023 | $440K |
| 2024 | $440K |
| 2025 | $330K |
Lobbying Firms
WELSH ROSE, LLC
What They Lobby For
- H.R. 1892, Bipartisan Budget Act of 2018, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Medicare and Medicaid reimbursement. Issues related to 340B drug pricing.
- H.R. 1892, Bipartisan Budget Act of 2018, all sections related to the Medicaid program, state options to expand Medicaid and the disproportionate share payment provisions. Issues related to Title V Maternal and Child Health Services Block Grants.
- Issues related to Medicare and Medicaid reform, drug pricing and NIH funding.
- Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement.
- Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding.
- S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019.
- Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act.
- Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act.
- Issues related to Medicare and Medicaid reform, drug pricing and NIH funding. Issues related to 42 CFR Part 2. Issues related to school based health center funding. Issues related to H.R.748/S.3548, CARES Act. H.R. 133, the Consolidated Appropriations Act of 2021; surprise billing.
- Issues related to 340B drug pricing. Issues related to Medicare & Medicaid reimbursement. Issues related to H.R.748/S.3548, CARES Act. H.R. 133, the Consolidated Appropriations Act of 2021 and issues related to COVID relief.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.